Sean David to Polymorphism, Genetic
This is a "connection" page, showing publications Sean David has written about Polymorphism, Genetic.
Connection Strength
1.344
-
Bupropion efficacy for smoking cessation is influenced by the DRD2 Taq1A polymorphism: analysis of pooled data from two clinical trials. Nicotine Tob Res. 2007 12; 9(12):1251-7.
Score: 0.224
-
Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation. Nicotine Tob Res. 2007 Aug; 9(8):821-33.
Score: 0.219
-
Genetic variation in the dopamine D4 receptor (DRD4) gene and smoking cessation: follow-up of a randomised clinical trial of transdermal nicotine patch. Pharmacogenomics J. 2008 Apr; 8(2):122-8.
Score: 0.214
-
Does the DRD2-Taq1 A polymorphism influence treatment response to bupropion hydrochloride for reduction of the nicotine withdrawal syndrome? Nicotine Tob Res. 2003 Dec; 5(6):935-42.
Score: 0.170
-
No association between functional catechol O-methyl transferase 1947A>G polymorphism and smoking initiation, persistent smoking or smoking cessation. Pharmacogenetics. 2002 Apr; 12(3):265-8.
Score: 0.151
-
Influence of a dopamine pathway additive genetic efficacy score on smoking cessation: results from two randomized clinical trials of bupropion. Addiction. 2013 Dec; 108(12):2202-11.
Score: 0.084
-
Pharmacogenetics of smoking cessation in general practice: results from the patch II and patch in practice trials. Nicotine Tob Res. 2011 Mar; 13(3):157-67.
Score: 0.070
-
The serotonin transporter 5-HTTLPR polymorphism and treatment response to nicotine patch: follow-up of a randomized controlled trial. Nicotine Tob Res. 2007 Feb; 9(2):225-31.
Score: 0.053
-
A functional genetic variation of the serotonin (5-HT) transporter affects 5-HT1A receptor binding in humans. J Neurosci. 2005 Mar 09; 25(10):2586-90.
Score: 0.046
-
Pharmacogenetics. Prim Care. 2004 Sep; 31(3):543-59, ix.
Score: 0.045
-
Effects of nicotine deprivation and replacement on BOLD-fMRI response to smoking cues as a function of DRD4 VNTR genotype. Nicotine Tob Res. 2014 Jul; 16(7):939-47.
Score: 0.022
-
Associations of CYP2A6 genotype with smoking behaviors in southern China. Addiction. 2011 May; 106(5):985-94.
Score: 0.018
-
A cost-effectiveness analysis of genetic testing of the DRD2 Taq1A polymorphism to aid treatment choice for smoking cessation. Nicotine Tob Res. 2008 Jan; 10(1):231-40.
Score: 0.014
-
Association of COMT Val108/158Met genotype with smoking cessation in a nicotine replacement therapy randomized trial. Cancer Epidemiol Biomarkers Prev. 2007 Jun; 16(6):1065-9.
Score: 0.014